Your browser doesn't support javascript.
loading
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study.
Abida, Wassim; Campbell, David; Patnaik, Akash; Bryce, Alan H; Shapiro, Jeremy; Bambury, Richard M; Zhang, Jingsong; Burke, John M; Castellano, Daniel; Font, Albert; Ganju, Vinod; Hardy-Bessard, Anne-Claire; McDermott, Ray; Sautois, Brieuc; Spaeth, Dominique; Voog, Eric; Piulats, Josep M; Pintus, Elias; Ryan, Charles J; Merseburger, Axel S; Daugaard, Gedske; Heidenreich, Axel; Fizazi, Karim; Loehr, Andrea; Despain, Darrin; Simmons, Andrew D; Dowson, Melanie; Go, Jowell; Watkins, Simon P; Chowdhury, Simon.
Afiliación
  • Abida W; Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: abidam@mskcc.org.
  • Campbell D; Barwon Health, University Hospital Geelong, Geelong, Victoria, Australia.
  • Patnaik A; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
  • Bryce AH; Mayo Clinic, Phoenix, AZ, USA.
  • Shapiro J; Cabrini Hospital, Malvern, Victoria, Australia.
  • Bambury RM; Cork University Hospital, Wilton, Cork, Ireland.
  • Zhang J; H. Lee Moffitt Cancer Center, Tampa, FL, USA.
  • Burke JM; Rocky Mountain Cancer Centers and US Oncology Research, Denver, CO, USA.
  • Castellano D; University Hospital 12 de Octubre, Madrid, Spain.
  • Font A; Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Ganju V; Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Hardy-Bessard AC; CARIO HPCA, Plérin, France.
  • McDermott R; Adelaide and Meath Hospital (Incorporating the National Children's Hospital), Dublin, Ireland.
  • Sautois B; Medical Oncology, University Hospital of Liège, CHU Sart Tilman, Liège, Belgium.
  • Spaeth D; Centre d'Oncologie de Gentilly, Nancy, France.
  • Voog E; Clinique Victor Hugo Centre Jean Bernard, Le Mans, France.
  • Piulats JM; Institut Català d'Oncologia, Barcelona, Spain.
  • Pintus E; Guy's & St Thomas' NHS Foundation Trust Hospital, London, UK.
  • Ryan CJ; University of Minnesota, Minneapolis, MN, USA.
  • Merseburger AS; University Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany.
  • Daugaard G; Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Heidenreich A; Universitätsklinikum Köln, Cologne, Germany; Department of Urology, Medical University Vienna, Vienna, Austria.
  • Fizazi K; Institut Gustave Roussy, University of Paris Saclay, Villejuif Cedex, France.
  • Loehr A; Clovis Oncology, Inc., Boulder, CO, USA.
  • Despain D; Clovis Oncology, Inc., Boulder, CO, USA.
  • Simmons AD; Clovis Oncology, Inc., Boulder, CO, USA.
  • Dowson M; Clovis Oncology UK, Ltd., Cambridge, UK.
  • Go J; Clovis Oncology, Inc., Boulder, CO, USA.
  • Watkins SP; Clovis Oncology UK, Ltd., Cambridge, UK.
  • Chowdhury S; Guy's & St Thomas' NHS Foundation Trust Hospital, London, UK.
Eur Urol ; 84(3): 321-330, 2023 09.
Article en En | MEDLINE | ID: mdl-37277275
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2023 Tipo del documento: Article